Gennova vaccine

India’s first mRNA-based Covid-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been given approval for phase 2/3 clinical trials, informed the department of biotechnology (DBT) said on Tuesday. It…

View Post

Spotlight

Race For A Covid-19 Vaccine: Four More Candidates In Pipeline

January 13, 2021 12:27
Healthwire Bureau

Although the Covishield vaccine by the Serum Institute of India and the indigenous Covaxin of Bharat Biotech are the two Covid-19 vaccines that will push the country’s vaccination program in…

View Post

Menu

Gennova vaccine

Gennova Vaccine Gets Nod For Phase 2/3 Trials

Race For A Covid-19 Vaccine: Four More Candidates In Pipeline

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients

Severe Strain of Bird Flu Spreading Rapidly: Is India at Risk of Another Pandemic?

India Achieves Significant Progress in Reducing Malaria Cases: WHO Report